Efanesoctocog alfa is an engineered form of factor VIII that overcomes the half-life ceiling imposed by von Willebrand factor. In this study, once-weekly prophylaxis in children led to highly effective bleeding prevention.
The New England Journal of Medicine: Search Results in Pediatrics
